文献速递认知障碍与痴呆帕金森病与运动障碍

β-淀粉样蛋白PET与路易体痴呆的神经病理学

β-Amyloid PET and neuropathology in dementia with Lewy bodies.
PubMed 文献 · Neurology · 2019-12-20

该研究纳入39例生前接受11C-PiB PET且尸检诊断为很可能DLB或LBD的病例,发现较低的全局皮层PiB SUVr以93%的准确率区分LBD与AD或混合病理,且PiB摄取与Thal Aβ相位相关,弥漫性Aβ斑块是LBD中PiB摄取升高的主要贡献者。

要点

  • 较低全局皮层PiB SUVr可准确区分LBD与AD或混合病理,准确率93%。
  • 全局皮层PiB SUVr越高,Thal Aβ相位越高(r=0.75,p≤0.001)。
  • LBD中PiB摄取升高主要与弥漫性Aβ斑块丰度相关。

核心结论

  • 较低的PiB摄取能准确区分LBD与AD或混合病理,并与Thal Aβ相位相关。
  • LBD中PiB摄取升高的主要病理基础是弥漫性Aβ病理的严重程度。

研究设计与样本

  • 尸检队列研究,纳入生前接受PiB-PET且尸检诊断为很可能DLB或LBD的病例39例。

主要发现

  • 较低全局皮层PiB SUVr区分LBD与AD或混合病理的准确率为93%。
  • 全局皮层PiB SUVr与Thal Aβ相位呈正相关(r=0.75,p≤0.001)。
  • 基于体素分析显示混合病理和LBD病例的Aβ病理相对避开枕叶,而AD无LBD病例整个大脑皮层均受累。
  • 多变量回归模型中,LBD病例的全局皮层PiB SUVr主要与弥漫性Aβ斑块丰度相关。

关键数值与推荐

  • 全局皮层PiB SUVr区分LBD与AD或混合病理的准确率为93%。
  • 全局皮层PiB SUVr与Thal Aβ相位相关(r=0.75,p≤0.001)。

临床怎么用

  • PiB-PET较低摄取有助于在临床很可能DLB病例中排除AD或混合病理。
  • PiB-PET摄取升高在LBD中应结合弥漫性Aβ斑块病理理解,而非必然提示AD。

局限性

  • 研究为Class III证据,样本量有限(n=39),结论需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: β-Amyloid (Aβ) pathology is common in patients with probable dementia with Lewy bodies (DLB). However, the pathologic basis and the differential diagnostic performance of Aβ PET are not established in DLB. Our objective was to investigate the pathologic correlates of 11C-Pittsburgh compound B(PiB) uptake on PET in cases with antemortem diagnosis of probable DLB or Lewy body disease (LBD) at autopsy. METHODS: Autopsied cases who underwent antemortem PiB-PET and were assigned a clinical diagnosis of probable DLB or LBD at autopsy were included (n = 39). The primary endpoint was pathologic diagnosis of LBD, Alzheimer disease (AD), or mixed (LBD and AD) pathology; the secondary endpoints included Thal Aβ phase and diffuse and neuritic Aβ plaques. RESULTS: Lower global cortical PiB standardized uptake value ratio (SUVr) distinguished cases with LBD from cases with AD or mixed pathology with an accuracy of 93%. Greater global cortical PiB SUVr correlated with higher Thal Aβ phase (r = 0.75, p ≤ 0.001). Voxel-based analysis demonstrated that Aβ pathology relatively spared the occipital lobes in cases with mixed pathology and LBD compared to cases with AD without LBD, in whom the entire cerebral cortex was involved. Global cortical PiB SUVr was associated primarily with the abundance of diffuse Aβ plaques in cases with LBD in a multivariable regression model. CONCLUSION: Lower PiB uptake accurately distinguishes cases with LBD from cases with AD or mixed pathology, correlating with the Thal Aβ phase. The severity of diffuse Aβ pathology is the primary contributor to elevated PiB uptake in LBD. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that lower PiB uptake accurately distinguishes patients with LBD from those with AD or mixed pathology.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Kantarci K, Lowe VJ, Chen Q, et al. β-Amyloid PET and neuropathology in dementia with Lewy bodies. Neurology. 2019. PMID: 31862783. doi:10.1212/WNL.0000000000008818

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。